Brief: Hester Biosciences Says Board Endorsed Plan To Work On Human Vaccines Development
April 29 (Reuters) - Hester Biosciences Ltd HEST.NS :
* CFO SAHIL SHAH RESIGNS
* APPOINTS CHETAS PATEL AS CFO
* BOARD ENDORSES CO'S PLAN TO WORK ON DEVELOPMENT OF HUMAN
VACCINES, BEGINNING WITH WORK ON COVID-19 DISEASE VACCINE
Source text for Eikon: ID:nBSE7b1pkv
Further company coverage: HEST.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hester Biosciences
See all newsIndia's Hester Biosciences jumps on quarterly profit rise
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD